MeVis Medical Solutions Past Earnings Performance
Past criteria checks 2/6
MeVis Medical Solutions's earnings have been declining at an average annual rate of -7.1%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been declining at an average rate of 0.2% per year. MeVis Medical Solutions's return on equity is 32.3%, and it has net margins of 32.6%.
Key information
-7.1%
Earnings growth rate
-7.1%
EPS growth rate
Healthcare Services Industry Growth | 7.9% |
Revenue growth rate | -0.2% |
Return on equity | 32.3% |
Net Margin | 32.6% |
Next Earnings Update | 30 Jan 2025 |
Recent past performance updates
Recent updates
MeVis Medical Solutions (ETR:M3V) Is Very Good At Capital Allocation
Nov 30Most Shareholders Will Probably Find That The CEO Compensation For MeVis Medical Solutions AG (ETR:M3V) Is Reasonable
Mar 16MeVis Medical Solutions (ETR:M3V) Has More To Do To Multiply In Value Going Forward
Feb 14Should You Use MeVis Medical Solutions' (ETR:M3V) Statutory Earnings To Analyse It?
Feb 22MeVis Medical Solutions AG's (ETR:M3V) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?
Feb 01Revenue & Expenses Breakdown
How MeVis Medical Solutions makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 18 | 6 | 1 | 0 |
31 Dec 23 | 17 | 5 | 1 | 0 |
30 Sep 23 | 17 | 5 | 1 | 0 |
30 Jun 23 | 18 | 6 | 1 | 0 |
31 Mar 23 | 19 | 6 | 1 | 0 |
31 Dec 22 | 19 | 7 | 1 | 0 |
30 Sep 22 | 19 | 8 | 1 | 0 |
30 Jun 22 | 18 | 7 | 0 | 0 |
31 Mar 22 | 17 | 6 | 0 | 0 |
31 Dec 21 | 16 | 5 | 0 | 0 |
30 Sep 21 | 16 | 5 | 0 | 0 |
30 Jun 21 | 16 | 5 | 0 | 0 |
31 Mar 21 | 17 | 5 | 0 | 0 |
31 Dec 20 | 17 | 5 | 0 | 0 |
30 Sep 20 | 17 | 6 | 0 | 0 |
30 Jun 20 | 18 | 7 | 1 | 0 |
31 Mar 20 | 18 | 7 | 1 | 0 |
31 Dec 19 | 18 | 7 | 0 | 0 |
30 Sep 19 | 18 | 8 | 0 | 0 |
30 Jun 19 | 19 | 8 | 0 | 0 |
31 Mar 19 | 18 | 9 | 0 | 0 |
31 Dec 18 | 17 | 8 | 1 | 0 |
30 Sep 18 | 18 | 8 | 0 | 0 |
30 Jun 18 | 16 | 7 | 1 | 0 |
31 Mar 18 | 17 | 4 | 1 | 0 |
31 Dec 17 | 17 | 3 | 1 | 0 |
30 Sep 17 | 19 | 6 | 1 | 0 |
30 Jun 17 | 19 | 5 | 1 | 0 |
31 Mar 17 | 18 | 7 | 1 | 0 |
31 Dec 16 | 18 | 8 | 1 | 0 |
30 Sep 16 | 16 | 7 | 1 | 0 |
30 Jun 16 | 17 | 7 | 1 | 0 |
31 Mar 16 | 16 | 6 | 1 | 0 |
31 Dec 15 | 16 | 7 | 1 | 0 |
30 Sep 15 | 15 | 3 | 1 | 0 |
30 Jun 15 | 15 | 3 | 1 | 0 |
31 Mar 15 | 14 | 4 | 1 | 0 |
31 Dec 14 | 14 | 4 | 1 | 0 |
30 Sep 14 | 14 | 4 | 0 | 0 |
30 Jun 14 | 14 | 4 | 0 | 0 |
31 Mar 14 | 14 | 4 | 0 | 0 |
31 Dec 13 | 14 | 4 | 0 | 0 |
Quality Earnings: M3V has high quality earnings.
Growing Profit Margin: M3V's current net profit margins (32.6%) are lower than last year (33.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: M3V's earnings have declined by 7.1% per year over the past 5 years.
Accelerating Growth: M3V's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: M3V had negative earnings growth (-7.2%) over the past year, making it difficult to compare to the Healthcare Services industry average (3.6%).
Return on Equity
High ROE: M3V's Return on Equity (32.3%) is considered high.